The Eye of a Survivor

While cure remains a goal, unique issues arise when treating professional and amateur athletes for hematologic conditions. Athletic competition on an elite level depends on substantial training to optimize performance, and while many may not...

Online Exclusives

Americans Owe $140 Billion in Medical Debt Sold to Collections Agencies

Americans owe $140 billion in medical debt that has been sold to collections agencies, according to research published in the Journal of the American...

FDA Supports Inclusion of Pregnant and Breastfeeding Women in Clinical Trials

Officials at the U.S. Food and Drug Administration (FDA) have announced their commitment to work with other regulators and industry to support the inclusion...

News

From the Blood Journals

Post-Transplant High-Dose Chemotherapy Increases Risk of Toxicities in Older Patients with...

Most patients with lymphoma who are over age 60 experience cardiovascular toxicities with high-dose chemotherapy and autologous hematopoietic cell transplantation (AHCT), but these patients...

Pain, Comorbidities Increase Risk of Severe COVID-19 in Patients with SCD

Research published in Blood Advances found patients with sickle cell disease (SCD) and a history of pain and renal and heart/lung comorbidities have a...

Sponsored Content

Multimedia

Kathi Mooney: Impact of Remote Monitoring on Patients with Cancer During...

Remote monitoring and treatment of cancer and treatment-related symptoms during the COVID-19 pandemic was associated with significant reductions in symptom burden and improvements in...

Ann LaCasce: PET Adapted Therapy Allows Omission of Radiation Therapy in...

Ann S. LaCasce, MD, shares data from the Alliance for Clinical Trials in Oncology’s CALGB-50801 trial, which evaluated a PET-adapted approach to cHL therapy.

Paolo Ghia: Ibrutinib Plus Venetoclax Produces Deep Responses in Patients with...

Here, Paolo Ghia, MD, PhD, of Vita-Salute San Raffaele University in Milan, Italy, discusses recent findings from the phase II CAPTIVATE study evaluating fixed-duration...

Vincent Wagner and Ellen Marcus: Use of the Khorana Score to...

Vincent Wagner, MD, and Ellen Marcus, BA, discuss the Khorana score's role in assessing risk of venous thromboembolism (VTE) in patients with gynecological cancers.

On Location

On location

Investigating the Combination of Ivosidenib Plus Venetoclax and Azacitidine in IDH-Mutated Myeloid Malignancies

In a small study of patients with IDH1-mutated myeloid malignancies, treatment with ivosidenib plus venetoclax, with or without azacitidine,...
On location

Evaluating Two New Options for Hereditary Hemorrhagic Telangiectasia

At EHA2021 Virtual, researchers shared safety and efficacy findings of two agents for the treatment...
On location

Ibrutinib Plus Rituximab Shows Efficacy in Indolent Mantle Cell Lymphoma

In the GELTAMO ICML-2015 study, treatment with frontline ibrutinib in combination with rituximab demonstrated high...
On location

Evaluating a Response-Adapted Rituximab Approach for Patients With Follicular Lymphoma

In patients with follicular lymphoma (FL), standard rituximab maintenance produced better rates of progression-free survival...
On location

Does Khorana Score Accurately Predict VTE in Patients With Uterine and Ovarian Cancer?

At the 2021 ASCO Annual Meeting, researchers shared results from two studies examining the Khorana...
On location

PDE9 Inhibitor Shows Promise as Monotherapy and With Hydroxyurea in Sickle Cell Disease

Data from two new studies indicated that daily dosing of the oral phosphodiesterase type 9...

Latest Headlines

Advertisement

ASH Directions

ASH Directions

ASH Announces 2021 ASH Honorific Award Recipients, Issues New Guidance on Anticoagulation for Discharged...

Congratulations to the Recipients of the 2021 ASH Honorific Awards! The American Society of Hematology (ASH) has announced the recipients of its 2021 Honorific Awards,...
ASH Directions

ASH Responds to Investigation on SCT in Policy Custody Deaths, ASH Hematology Review Series...

ASH Responds to Investigation on Sickle Cell Trait Being Cited in Policy Custody Deaths The American Society of Hematology (ASH) has issued a position...

Sign up for our
eNewsletter!

The Society Pages

ASH Remembers Joel S. Bennett, Cancer Researchers Win Damon Runyon Physician-Scientist Training Awards, and...

Remembering Joel S. Bennett (1942 – 2021) Joel S. Bennett, MD, died of pancreatic cancer on June 21, 2021, at the age of 78.Aside from...
The Society Pages

SAACR Awards Indian Americans for Cancer Research Discoveries, GBT Awards $450k to SCD Care...

Catherine Bollard Recognized for Mentorship and Cell-Based Therapy Research Catherine Bollard, MD, MBChB, director of the Center for Cancer and Immunology Research at Children’s National...
The Society Pages

Remembering Thomas Brock, Xavier Becerra Confirmed as U.S. Health Secretary, and more

Remembering Thomas Brock (1926 - 2021) Thomas Brock, PhD, died on April 4, 2021 at the age of 94. Dr. Brock’s discovery of a species...

The Eye of a Survivor

While cure remains a goal, unique issues arise when treating professional and amateur athletes for hematologic conditions. Athletic competition on an elite level depends on...

Transforming Ideas into Research Reality

Participants come to the ASH Clinical Research Training Institute with ideas and enthusiasm, and leave with new skills to conduct patient-oriented research. Just 20 years...

Breaking Down Barriers, Building Up Trust

Clinical trial enrollment has lacked diversity since the start, but a global racial reckoning has brought new attention to overcoming discrimination. According to the most...